Efficiently Inhibiting Systemic Inflammatory Cascades by Fullerenes for Retarding HFD‐Fueled Atherosclerosis
Authors:
- 16 January 2023
- journal article
- research article
- Published by Wiley in Advanced Healthcare Materials
- Vol. 12 (11) , e2202161
Abstract
Atherosclerosis accounts for major mortality of cardiac‐cerebral vascular diseases worldwide. Pathologically, persistent inflammation dominates the progression of atherosclerosis, which can be accelerated by a high‐fat diet (HFD), possibly through triggering local intestinal oxidative stress and ensuing gut barrier dysfunction. Current pharmacotherapy has been disappointing, ascribed to limited therapeutic efficacy and undesirable side effects. Hence it is compelling to explore novel efficient anti‐atherosclerotic drugs with minimal toxicity. Herein, two fullerene‐based therapies with exceptional antioxidant capacity, in the form of water‐soluble injectable fullerene nanoparticles (IFNPs) and oral fullerene tablets (OFTs), are demonstrated to retard HFD‐fueled atherosclerosis in ApoE−/‐ mice with favorable biosafety. Especially, OFTs afford robust anti‐atherosclerotic therapeutic even against advanced plaques, besides stabilizing plaques with less lipid deposition and improved collagen expression. Specifically, it is identified that OFTs can ameliorate HFD‐induced dysregulated intestinal redox homeostasis and restore gut barrier integrity, thereby restraining the translocation of luminal lipopolysaccharide (LPS) into the bloodstream. Furthermore, significantly reduced circulating LPS after OFTs treatment contributes to down‐regulated LPS/TLR4/NF‐κB signaling in aortic focal, which further mitigates local inflammation and disease development. Overall, this study confirms the universal anti‐atherosclerotic effect of fullerenes and provides a novel therapeutic mechanism via modulating intestinal barrier to attenuate atherosclerosis.Keywords
Funding Information
- National Natural Science Foundation of China (52172055)
This publication has 38 references indexed in Scilit:
- From Lipids to InflammationCirculation Research, 2016
- Macrophage Phenotype and Function in Different Stages of AtherosclerosisCirculation Research, 2016
- Inflammatory cytokines in atherosclerosis: current therapeutic approachesEuropean Heart Journal, 2016
- Therapeutic applications of low-toxicity spherical nanocarbon materialsNPG Asia Materials, 2014
- The heart and the gutEuropean Heart Journal, 2013
- Radical Reactions of Fullerenes: From Synthetic Organic Chemistry to Materials Science and BiologyChemical Reviews, 2013
- Metabolic endotoxaemiaCurrent Opinion in Lipidology, 2013
- Anti-inflammatory therapeutics for the treatment of atherosclerosisNature Reviews Drug Discovery, 2011
- Metabolic Endotoxemia Initiates Obesity and Insulin ResistanceDiabetes, 2007
- Antioxidative function and biodistribution of [Gd@C82(OH)22]n nanoparticles in tumor-bearing miceBiochemical Pharmacology, 2006